Transcranial direct current stimulation shows promise for treating depression, anxiety in older adults

A noninvasive brain stimulation treatment improved depression and anxiety symptoms among older adults in a new University of Florida-led study.

How AI can advance research and treatment of CNS disorders

By Xiao Xu, senior research fellow, Cerevance The combination of large-scale biological datasets and developments in artificial intelligence (AI) has revolutionized our understanding and treatment

June 13, 2023

CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE – Biotech Investments

Issuer: CureVac / Key word(s): Patent 19.12.2023 / 15:23 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Decision of

December 20, 2023

Biotech index rises above $100 mark for first time in two years

After a roller coaster of a two-year ride, the biotech market’s key stock index, the $XBI, surpassed the $100 mark on Tuesday, buoying investor optimism

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.